ISONO HEALTH, INC.

SOUTH SAN FRANCISCO, CA · Medtech · Private

ATUSA, an adjustable wearable ultrasound imaging device for breast cancer screening

Claim this profile

Follows are private to you and power your alerts

Updated · isonohealth.com

Sector
Medtech
Headquarters
SOUTH SAN FRANCISCO, CA
Latest Form D
$1.8M, Mar 2025
Total capital
$5.5M
Federal grants
$3.7M
4 awards · 2017–2025
Rank in peer group#253 of 538
Private capital raised
$1.8M
1 Form D · last Mar 2025
19 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
3 pending · first 2023
Rank in peer group#190 of 538

Capital timeline

20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $5.5M$225K$1.5M$1M$957K1st Form D$1.8M
20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $5.5M$225K$1.5M$1M$957K1st Form D$1.8M

Latest events

  • Federal grantHealth and Human S · Phase II · ATUSA: World's First Wearable and Automated 3D Breast Ultrasound System with AI$957K
  • Private capital raisedForm D · SEC · 1st filing$1.8M
  • Federal grantHealth and Human S · Phase II · ATUSA: World's First Wearable and Automated 3D Breast Ultrasound System with AI$1M
  • Federal grantNSF · Phase II · SBIR Phase II: Compact, Low-cost, Automated 3D Ultrasound System for Regular and Accessible Breast Imaging$1.5M
  • Federal grantNSF · Phase I · SBIR Phase I: Compact, Low-cost, Automated 3D Ultrasound System for Regular and Accessible Breast Imaging$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

93months

from ISONO HEALTH, INC.’s first federal award to its first private round.

First federal award · Jun 2017
NSF · $225K
First Form D · Mar 2025
$1.8M · 1st Form D
Awards before first raise
3 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#253 · top 47%
  • Granted patents#190 · top 35%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Shadi SaberiResearcherDirectorLinked by 2 patents · $2M in grants as PI
  • Michael JinDirectorNamed in SEC Form D filings
  • Neda RazaviExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 5
Show all 5 patent records
  • ECLIPSE ENTEROGENESIS, INC.Similar federal contract value in Medtech · null in contracts
  • VenoStent, Inc.Similar federal contract value in Medtech · null in contracts
  • REBEL MEDICINE INCSimilar federal contract value in Medtech · null in contracts
  • Sonavex, Inc.Similar federal contract value in Medtech · null in contracts
  • MISSION BIO, INC.Similar federal contract value in Medtech · null in contracts
  • Sonorous NV, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .